In response to the unfolding COVID-19 public health crisis, federal agencies have announced new chan...
FDA Program for Reducing Unsafe Opioid Prescribing and Adverse Events Fails to Produce Clear Results
It is unclear whether the government’s strategy for reducing unsafe opioid prescribing and adverse e...
The Food and Drug Administration (FDA) has approved Sublocade, the first once-monthly injectable bup...
